MAHON PAUL A (EVP & GENERAL COUNSEL) sold 15.5% of their position (8.30K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.79M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+8.30K
Price / share
$146.03
Trade value
$1.21M
% of position
Common Stock
Shares
−200.00
Price / share
$574.03
Trade value
$114.81K
% of position
Common Stock
Shares
−1.64K
Price / share
$575.37
Trade value
$943.61K
% of position
Common Stock
Shares
−1.80K
Price / share
$576.38
Trade value
$1.04M
% of position
Common Stock
Shares
−3.37K
Price / share
$577.39
Trade value
$1.94M
% of position
Common Stock
Shares
−1.29K
Price / share
$578.21
Trade value
$748.20K
% of position
Net shares
+0.00
Net value
-$3.58M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | M · Option Exercise | +8.30K | $146.03 | $1.21M | 18.4% | 45.17K | 53.47K |
| Common Stock Direct | 4/16/2026 | S · Sale | −200.00 | $574.03 | $114.81K | 0.4% | 53.47K | 53.27K |
| Common Stock Direct | 4/16/2026 | S · Sale | −1.64K | $575.37 | $943.61K | 3.1% | 53.27K | 51.63K |
| Common Stock Direct | 4/16/2026 | S · Sale | −1.80K | $576.38 | $1.04M | 3.5% | 51.63K | 49.83K |
| Common Stock Direct | 4/16/2026 | S · Sale | −3.37K | $577.39 | $1.94M | 6.8% | 49.83K | 46.47K |
| Common Stock Direct | 4/16/2026 | S · Sale | −1.29K | $578.21 | $748.20K | 2.8% | 46.47K | 45.17K |
| Total | +0.00 | -$3.58M | ||||||
Stock Option
Common Stock
8.30K shares
Shares
−8.30K
Strike price
146.03
Held after
8.60K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock8.30K shares | 4/16/2026 | M · Option Exercise | −8.30K | 146.03 | — | 8.60K |